MDS is a bone marrow failure disorder

Welcome to the MDS Patient Message Board Post New Thread

Welcome to the MDS Patient Message Board. We hope that you will find this to be a very valuable resource in your journey. We have recently revised the format of our forum to be much more user friendly and pleasing on the eyes. Let us know if you have any problems, or if you have additional suggestions on how we might further improve our site.

For high risk MDS, CMML, and low-blast AML

HomeForumsPatient Message BoardFor high risk MDS, CMML, and low-blast AML

This topic contains 0 replies, has 1 voice, and was last updated by  Site Admin 1 month, 1 week ago.

Viewing 1 post (of 1 total)
  • Author
    Posts
  • #32092

    Site Admin
    Moderator

    The MDS Foundation is partnering with Takeda to conduct observational research in patients with high risk MDS, CMML, and low-blast AML. The overall objective of this research is to better understand the patient perspective of symptom experience and impact on health-related quality of life among patients with MDS and AML. This study has received independent IRB approval and would involve a telephone interview with high-risk MDS, CMML, and low-blast AML patients with a Modus Outcomes researcher trained in scientific qualitative research. The telephone interview will last approximately one hour and patients will receive monetary compensation for their participation.

    If you are interested in participating in the interview or for more information, contact Anna Christian at 781-608-3871 or via email at research@modusoutcomes.com.

Viewing 1 post (of 1 total)

Register for an account, or login to post to our message boards. Click here.

You must be logged in to reply to this topic.

Login

Search Forums

Review answers to commonly asked questions or get answers to your questions from an MDS expert